
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Septin 8 CRISPR/Cas9 KO Plasmid (m) | sc-422891 | 20 µg | $397.00 |
Sept8 encodes septin 8, a GTP-binding cytoskeletal protein that assembles into hetero-oligomeric septin filaments and ring-like structures that scaffold membranes and organize the actin–microtubule interface. Septin 8 contributes to cytokinesis, cell polarity, and vesicle trafficking, and it helps compartmentalize signaling by forming diffusion barriers at specialized membrane domains. In neurons, septin complexes containing septin 8 are linked to neurite morphogenesis and synaptic organization, supporting studies of development and circuit maintenance in mouse models. Dysregulated septin network dynamics have been associated with altered cell division and cytoskeletal remodeling observed in cancer and neurodegenerative research contexts, making Sept8 a useful target for mechanistic pathway interrogation.
Septin 8 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sept8 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sept8 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sept8 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Septin 8 protein expression.
This CRISPR knockout system enables efficient generation of Sept8-deficient cell models for investigation of Septin 8 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.